Reshwan K. Malahe

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 05, 2024

Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial.

Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial.

Journal: Transplantation
Published: June 21, 2024

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study.

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 21, 2023

Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients.

Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients.

Journal: Npj viruses
Published: November 10, 2023

SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.

SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.

Journal: NPJ vaccines
Published: October 31, 2023

Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients.

Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients.

Journal: Viruses
Published: June 16, 2023

The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.

The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: November 01, 2022

Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.

Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.

Journal: NPJ vaccines
Published: October 04, 2022

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.

Journal: The Lancet. Infectious diseases
Published: July 28, 2022

Boosting the VZV-Specific Memory B and T Cell Response to Prevent Herpes Zoster After Kidney Transplantation.

Boosting the VZV-Specific Memory B and T Cell Response to Prevent Herpes Zoster After Kidney Transplantation.

Journal: Frontiers in immunology
Published: April 24, 2022

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 01, 2022

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Journal: Transplantation
Published: November 10, 2021
Showing 1-12 of 13

Last Updated: 09/26/2026